Site Wide Notice

Coronavirus Update - 24th March 2020

We understand our customers concerns relating to the spread of COVID-19 and would like to assure you that we are located in one of the least affected areas of the UK and are open for business as usual.

Click here for latest information

Our work and case studies


Accelerate first-in-human and Phase II trials for an oral dosage form intended for treatment of CNS disorders. A fully integrated approach was required, to include drug substance manufacture, formulation development, GMP clinical manufacture, IMP packaging, labelling and assembly, distribution, and compilation of a CMC dossier.


Small biotech (Europe)


A fully integrated pharmaceutical development package, involving all disciplines to include API manufacture, formulation development, product manufacture, analytical method development/validation, QC/QA release, and CMC regulatory document compilation, was successfully delivered to satisfy aggressive timelines. Phase I and multi-centre Phase II studies were completed with confirmation of proof-of-concept, and ownership of the drug substance transferred to a large pharmaceutical company with continued support from Arcinova. 

API Manufacture, Formulation Development, Capsule Product Manufacture Case Study